{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=76", "query": { "intervention": "Control Study Product", "page": 76 }, "page_size": 10 }, "pagination": { "page": 76, "page_size": 10, "total_count": 4242, "total_pages": 425, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=77&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=75&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-03T14:32:11.081Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01775813", "title": "The Health Influences of Puberty (HIP) Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Obesity", "Insulin Resistance", "Gonadal Dysfunction", "Type 2 Diabetes" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "9 Years to 17 Years" }, "enrollment_count": 104, "start_date": "2011-06", "completion_date": "2018-05-31", "has_results": true, "last_update_posted_date": "2022-02-01", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01775813" }, { "nct_id": "NCT06535854", "title": "Prevail Global Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Prevail DCB", "type": "DEVICE" }, { "name": "Agent DCB", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic Vascular", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1205, "start_date": "2025-02-24", "completion_date": "2031-02", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Tucson, Arizona + 48 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06535854" }, { "nct_id": "NCT02665286", "title": "Orphenadrine and Methocarbamol for LBP", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Low Back Pain" ], "interventions": [ { "name": "Orphenadrine", "type": "DRUG" }, { "name": "Methocarbamol", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 240, "start_date": "2016-03", "completion_date": "2017-05", "has_results": true, "last_update_posted_date": "2018-06-26", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02665286" }, { "nct_id": "NCT01439373", "title": "Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "GSK2336805", "type": "DRUG" }, { "name": "Pegylated interferon alfa-2a", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" }, { "name": "GSK2336805 Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 16, "start_date": "2011-07-07", "completion_date": "2011-12-05", "has_results": true, "last_update_posted_date": "2017-12-11", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 9, "location_summary": "Anaheim, California • Chula Vista, California • Coronado, California + 6 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Coronado", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01439373" }, { "nct_id": "NCT03715829", "title": "A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Active Non-segmental Vitiligo" ], "interventions": [ { "name": "PF-06651600", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "PF06700841", "type": "DRUG" }, { "name": "narrow-band UVB phototherapy", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 366, "start_date": "2018-11-26", "completion_date": "2021-02-05", "has_results": true, "last_update_posted_date": "2022-03-25", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 40, "location_summary": "Huntington Beach, California • Irvine, California • Los Angeles, California + 25 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03715829" }, { "nct_id": "NCT00623766", "title": "Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "Ipilimumab", "type": "DRUG" }, { "name": "Corticosteroid: Betamethasone", "type": "DRUG" }, { "name": "Corticosteroid: Dexamethasone", "type": "DRUG" }, { "name": "Corticosteroid: Fludrocortisone", "type": "DRUG" }, { "name": "Corticosteroid: Hydrocortisone", "type": "DRUG" }, { "name": "Corticosteroid: Meprednisone", "type": "DRUG" }, { "name": "Corticosteroid: Methylprednisolone", "type": "DRUG" }, { "name": "Corticosteroid: Prednisolone", "type": "DRUG" }, { "name": "Corticosteroid: Prednisone", "type": "DRUG" }, { "name": "Corticosteroid: Triamcinolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 99, "start_date": "2008-07", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 14, "location_summary": "Scottsdale, Arizona • Duarte, California • Los Angeles, California + 11 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00623766" }, { "nct_id": "NCT02091596", "title": "Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Foot Ulcer", "Infection" ], "interventions": [ { "name": "PluroGel N", "type": "DRUG" }, { "name": "PluroGel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PluroGen Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2013-10", "completion_date": "2014-09", "has_results": false, "last_update_posted_date": "2014-09-25", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Los Angeles, California • Oakland, California + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Hamden", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02091596" }, { "nct_id": "NCT07138274", "title": "Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mild Autonomous Cortisol Secretion (MACS)", "Autonomous Cortisol Secretion (ACS)" ], "interventions": [ { "name": "Metyrapone 250 mg Oral Tablets", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2026-10", "completion_date": "2031-12", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07138274" }, { "nct_id": "NCT00557180", "title": "Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma", "Obesity" ], "interventions": [ { "name": "Beclomethasone dipropionate HFA", "type": "DRUG" }, { "name": "Tiotropium bromide", "type": "DRUG" }, { "name": "Salmeterol xinafoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Jewish Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2007-10", "completion_date": "2011-02", "has_results": false, "last_update_posted_date": "2020-10-22", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 10, "location_summary": "San Diego, California • San Francisco, California • Denver, Colorado + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00557180" }, { "nct_id": "NCT04938427", "title": "A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lennox Gastaut Syndrome (LGS)" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Soticlestat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "2 Years to 55 Years" }, "enrollment_count": 270, "start_date": "2021-11-08", "completion_date": "2024-01-25", "has_results": true, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-11-03T14:32:11.081Z", "location_count": 24, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Los Angeles, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04938427" } ] }